Schindler, T. (2026). Will the Food and Drug Administration’s New Standard of Requiring Only One Trial for a New Drug Application/Biologic License Application Have Repercussions for Medical Communicators?. AMWA Journal, 41(2). https://doi.org/10.55752/amwa.2026.569